Results 281 to 290 of about 585,044 (300)

New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis and Cardiovascular Disease

Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
Alexandros Tselepis
exaly  

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

Clinical Chemistry, 1972
Donald S Fredrickson, Robert I Levy
exaly  

HEART UK consensus statement on Lipoprotein(a): A call to action

Atherosclerosis, 2019
Julian Halcox, Gordon Ferns, Adie Viljoen   +2 more
exaly  

Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

Circulation, 2008
Hector Manuel Garcia-Garcia, Hans Erik Bøtker   +1 more
exaly  

[Lipoprotein and lipoprotein subfraction].

Nihon rinsho. Japanese journal of clinical medicine, 1999
openaire   +2 more sources

The Abnormal ‘Lipoprotein of Cholestasis’, Lipoprotein-X

Scandinavian Journal of Gastroenterology, 1975
openaire   +2 more sources

Lipoprotein Lipase

1975
T, Olivecrona, O, Hernell, T, Egelrud
openaire   +2 more sources

Regulation of High-Density Lipoprotein Metabolism

Circulation Research, 2014
Kerry-Anne Rye
exaly  

Beyond Low-Density Lipoprotein Cholesterol

Journal of the American College of Cardiology, 2009
Erik Stroes, Matthijs Boekholdt, Jean-Pierre Despres   +2 more
exaly  

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events

Circulation, 2017
Samia Mora, Amit Khera, Robert Glynn
exaly